{"disease":{"id":"epidermal-nevus-syndrome-ens","name":"epidermal nevus syndrome ens"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02304367","title":"Study of Burosumab (KRN23) in Adults With Tumor-Induced Osteomalacia (TIO) or Epidermal Nevus Syndrome (ENS)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":17,"lead_sponsor_name":"Kyowa Kirin, Inc.","has_results":true}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}